NICE Opens Routine NHS Access to Two SMA Treatments in England
NICE recommends routine NHS access to nusinersen and risdiplam for eligible SMA patients in England.
NICE and MHRA decisions, newly approved medicines and treatments, and the rules that govern how care is delivered.
NICE backs first targeted treatment for uncontrolled myasthenia gravis
NICE recommends rozanolixizumab for uncontrolled myasthenia gravis, offering a new NHS treatment option for adults in England.
UK Clinical Trials Overhaul Comes Into Force, Promising Faster Access to New Treatments
UK clinical trials reforms take effect, aiming to speed approvals and give patients faster access to new treatments.
New UK-linked research highlights precision care gains in heart and cancer medicine
New 5 May 2026 research in Nature highlights advances in cardiac imaging and targeted cancer vaccination.
NICE Recommends First Treatment for Uncontrolled Generalised Myasthenia Gravis
NICE recommends rozanolixizumab for uncontrolled generalised myasthenia gravis, offering a new NHS treatment option in England.
NICE Updates Fertility Care Pathway as Endometriosis Patients Gain Clearer Access to Treatment
NICE has introduced a dedicated fertility pathway for endometriosis patients, aiming for clearer, more personalised NHS care.
NICE Adds Dedicated Fertility Pathway for Endometriosis Patients
NICE has added a dedicated fertility pathway for endometriosis, aiming to improve personalised care and reduce variation.
NICE and MHRA Fast-Track New Medicines to NHS Patients Under Aligned Approval Pathway
NICE and MHRA launch a new aligned pathway to speed up access to medicines for NHS patients in the UK.
